165 related articles for article (PubMed ID: 11144380)
1. Single dose pharmacokinetics of linezolid in infants and children.
Kearns GL; Abdel-Rahman SM; Blumer JL; Reed MD; James LP; Jacobs RF; Bradley JA; Welshman IR; Jungbluth GL; Stalker DJ;
Pediatr Infect Dis J; 2000 Dec; 19(12):1178-84. PubMed ID: 11144380
[TBL] [Abstract][Full Text] [Related]
2. Linezolid pharmacokinetics in pediatric patients: an overview.
Jungbluth GL; Welshman IR; Hopkins NK
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S153-7. PubMed ID: 14520140
[TBL] [Abstract][Full Text] [Related]
3. Impact of ontogeny on linezolid disposition in neonates and infants.
Kearns GL; Jungbluth GL; Abdel-Rahman SM; Hopkins NK; Welshman IR; Grzebyk RP; Bruss JB; Van Den Anker JN;
Clin Pharmacol Ther; 2003 Nov; 74(5):413-22. PubMed ID: 14586382
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers.
Stalker DJ; Jungbluth GL; Hopkins NK; Batts DH
J Antimicrob Chemother; 2003 May; 51(5):1239-46. PubMed ID: 12668582
[TBL] [Abstract][Full Text] [Related]
5. Linezolid pharmacokinetics in adult patients with cystic fibrosis.
Bosso JA; Flume PA; Gray SL
Antimicrob Agents Chemother; 2004 Jan; 48(1):281-4. PubMed ID: 14693551
[TBL] [Abstract][Full Text] [Related]
6. Age and sex effects on the pharmacokinetics of linezolid.
Sisson TL; Jungbluth GL; Hopkins NK
Eur J Clin Pharmacol; 2002 Jan; 57(11):793-7. PubMed ID: 11868801
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of linezolid in children with cystic fibrosis.
Santos RP; Prestidge CB; Brown ME; Urbancyzk B; Murphey DK; Salvatore CM; Jafri HS; McCracken GH; Ahmad N; Sanchez PJ; Siegel JD
Pediatr Pulmonol; 2009 Feb; 44(2):148-54. PubMed ID: 19137597
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial.
Stalker DJ; Jungbluth GL
Clin Pharmacokinet; 2003; 42(13):1129-40. PubMed ID: 14531724
[TBL] [Abstract][Full Text] [Related]
9. Intrapulmonary pharmacokinetics of linezolid.
Conte JE; Golden JA; Kipps J; Zurlinden E
Antimicrob Agents Chemother; 2002 May; 46(5):1475-80. PubMed ID: 11959585
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and tissue penetration of linezolid following multiple oral doses.
Gee T; Ellis R; Marshall G; Andrews J; Ashby J; Wise R
Antimicrob Agents Chemother; 2001 Jun; 45(6):1843-6. PubMed ID: 11353635
[TBL] [Abstract][Full Text] [Related]
11. Linezolid for the treatment of community-acquired pneumonia in hospitalized children. Linezolid Pediatric Pneumonia Study Group.
Kaplan SL; Patterson L; Edwards KM; Azimi PH; Bradley JS; Blumer JL; Tan TQ; Lobeck FG; Anderson DC;
Pediatr Infect Dis J; 2001 May; 20(5):488-94. PubMed ID: 11368105
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetic evaluation of linezolid in patients with major thermal injuries].
Le Floch R; Arnould JF; Vinsonneau C; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Lovering AM
Pathol Biol (Paris); 2010 Apr; 58(2):e27-31. PubMed ID: 19854590
[TBL] [Abstract][Full Text] [Related]
13. Linezolid clearance during continuous venovenous hemodiafiltration: a case report.
Kraft MD; Pasko DA; DePestel DD; Ellis JJ; Peloquin CA; Mueller BA
Pharmacotherapy; 2003 Aug; 23(8):1071-5. PubMed ID: 12921253
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of intravenous and oral linezolid in adults with cystic fibrosis.
Keel RA; Schaeftlein A; Kloft C; Pope JS; Knauft RF; Muhlebach M; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2011 Jul; 55(7):3393-8. PubMed ID: 21518837
[TBL] [Abstract][Full Text] [Related]
15. Use of linezolid in children. Introduction.
Kaplan SL
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S151-2. PubMed ID: 14520139
[No Abstract] [Full Text] [Related]
16. Pharmacokinetics of linezolid in bone tissue investigated by in vivo microdialysis.
Stolle LB; Plock N; Joukhadar C; Arpi M; Emmertsen KJ; Buerger C; Riegels-Nielsen P; Kloft C
Scand J Infect Dis; 2008; 40(1):24-9. PubMed ID: 18097982
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of linezolid in patients treated in a compassionate-use program.
Meagher AK; Forrest A; Rayner CR; Birmingham MC; Schentag JJ
Antimicrob Agents Chemother; 2003 Feb; 47(2):548-53. PubMed ID: 12543657
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of linezolid in septic patients with and without extended dialysis.
Swoboda S; Ober MC; Lichtenstern C; Saleh S; Schwenger V; Sonntag HG; Haefeli WE; Hempel G; Hoppe-Tichy T; Weigand MA
Eur J Clin Pharmacol; 2010 Mar; 66(3):291-8. PubMed ID: 20013257
[TBL] [Abstract][Full Text] [Related]
19. Absolute bioavailability and pharmacokinetics of linezolid in hospitalized patients given enteral feedings.
Beringer P; Nguyen M; Hoem N; Louie S; Gill M; Gurevitch M; Wong-Beringer A
Antimicrob Agents Chemother; 2005 Sep; 49(9):3676-81. PubMed ID: 16127039
[TBL] [Abstract][Full Text] [Related]
20. Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration.
Fiscella RG; Lai WW; Buerk B; Khan M; Rodvold KA; Pulido JS; Labib S; Shapiro MJ; Blair NP
Ophthalmology; 2004 Jun; 111(6):1191-5. PubMed ID: 15177970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
